An evaluation of Bayesian designs for dose-escalation studies in healthy volunteers
John Whitehead(Lancaster City Council), Andrew Wright(GlaxoSmithKline (Sri Lanka)), Sally Y. Ritchie(GlaxoSmithKline (United Kingdom)), Adrian Mander(MRC Biostatistics Unit), Yinghui Zhou(Tesaro (United States)), Antony Sabin(GlaxoSmithKline (Sri Lanka))
Cited by 27
Related Papers
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
A general parametric approach to the meta‐analysis of randomized clinical trials
|Statistics in Medicine|1991|765
The Design and Analysis of Sequential Clinical Trials.
|Journal of the American Statistical Association|1985|638
The Design and Analysis of Sequential Clinical Trials.
|Biometrics|1997|523